6-K
Eupraxia Pharmaceuticals Inc. (EPRX)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OFFOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File Number 001-41923
EUPRAXIA PHARMACEUTICALS INC.
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name)
201-2067 Cadboro Bay Road
Victoria, British Columbia, Canada V8R 5G4
Telephone: (250) 590-3968
(Address and telephone number of registrant’s principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☐ Form 40-F ☒
INCORPORATIONBY REFERENCE
Exhibit 99.1 of this Form 6-K is incorporated by reference into the registrant’s Registration Statement on Form F-10 (File No. 333-276586) and the registrant’s Registration Statement on Form S-8 (333-278534).
DOCUMENTS INCLUDED AS PART OF THIS REPORT
| Exhibit | |
|---|---|
| 99.1 | Confirmation of Notice of Record and Meeting Dates, dated April 8, 2024 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Eupraxia Pharmaceuticals Inc. | ||
|---|---|---|
| Date: April 10, 2024 | By: | /s/ Bruce Cousins |
| Name: Bruce Cousins | ||
| Title: President and Chief Financial Officer |
EX-99.1
Exhibit 99.1
TSX TRUST COMPANY
VIA ELECTRONIC TRANSMISSION
April 8, 2024
TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:
| RE: | EUPRAXIA PHARMACEUTICALS INC. |
|---|
Confirmation of Notice of Record and Meeting Dates
We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities.
We advise the following with respect to the upcoming Annual General and Special Meeting of Security Holders for the subject issuer:
| 1 | ISIN: | CA29842P1053 |
|---|---|---|
| CUSIP: | 29842P105 | |
| 2 | Date Fixed for the Meeting: | June 6, 2024 |
| 3 | Record Date for Notice: | April 24, 2024 |
| 4 | Record Date for Voting: | April 24, 2024 |
| 5 | Beneficial Ownership Determination Date: | April 24, 2024 |
| 6 | Classes or Series of Securities that entitle the holder to receive Notice of the Meeting: | COMMON SHARES |
| 7 | Classes or Series of Securities that entitle the holder to vote at the meeting: | COMMON SHARES |
| 8 | Business to be conducted at the meeting: | Annual General and Special |
| 9 | Notice-and-Access: | |
| Registered Shareholders: | NO | |
| Beneficial Holders: | NO | |
| Stratification Level: | Not Applicable | |
| 10 | Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners: | NO |
| 11 | Issuer paying for delivery to Objecting Beneficial Owners: | NO |
Yours truly,
TSX TrustCompany
| VANCOUVER<br> <br>733 Seymour Street,<br><br><br>Suite #2310<br> <br>Vancouver, BC V6B 0S6<br><br><br><br> <br>T 604 689-3334 | CALGARY<br> <br>Telus Sky Building<br><br><br>2110, 685 Centre Street SW<br> <br>Calgary Alberta T2G 1S5<br><br><br><br> <br>T 403 218-2800 | TORONTO<br><br><br>301 - 100 Adelaide Street West<br><br><br>Toronto ON M5H 4H1<br> <br><br><br><br>Toll Free 1-866-600-5869<br><br><br>T 416 361-0930 | MONTRÉAL<br> <br>1701 - 1190, avenue<br>des<br> <br>Canadiens-de-Montréal, C. P. 37<br><br><br>Montréal (Québec) H3B 0G7<br> <br><br><br><br>T 514 395-5964 |
|---|